-
Practical Use of Oligo (dT) 25 Beads for mRNA Purification
2026-07-20
Oligo (dT) 25 Beads enable selective isolation of eukaryotic mRNA by capturing polyadenylated transcripts from total RNA or cell lysates. This product is best suited for workflows requiring high-quality mRNA for downstream applications such as RT-PCR, cDNA synthesis, or sequencing. It should not be used for prokaryotic RNA or protocols that require unselected total RNA.
-
STING-Mediated Antiviral DNA Sensing in Marine Invertebrates
2026-07-20
A recent study reveals that the marine shrimp STING ortholog can directly sense both viral DNA and cyclic dinucleotides, activating an IFN-like antiviral response. This finding provides evolutionary insight into nucleic acid sensing and innate immunity in invertebrates, expanding our understanding of antiviral defense beyond mammalian systems.
-
Cabazitaxel (XRP6258): Technical Use in Resistant Tumor Mode
2026-07-19
Cabazitaxel (XRP6258) addresses the challenge of modeling taxane-resistant and P-glycoprotein-expressing cancer cell lines, where classic taxanes are ineffective. It is strictly suited for DMSO- or ethanol-based workflows and should not be used in aqueous assays or for long-term solution storage due to solubility and stability constraints.
-
Lamotrigine in Translational Research: Sodium Channel and CY
2026-07-18
Lamotrigine’s unique profile as a sodium channel blocker and 5-HT inhibitor is now expanding into hormonal research, enabling reproducible workflows that span CNS, cardiac, and steroidogenic pathways. APExBIO’s high-purity 6-(2,3-dichlorophenyl)-1,2,4-triazine-3,5-diamine unlocks advanced protocols for epilepsy and endocrine disruption models.
-
Lamotrigine: Mechanistic Nuance and BBB Modeling in CNS Rese
2026-07-17
Explore Lamotrigine's unique role as a sodium channel blocker and 5-HT inhibitor in CNS research, with a focus on advanced blood-brain barrier modeling. This article provides a deeper analysis of permeability prediction and protocol strategies distinct from previous content.
-
Protease Inhibitor Cocktail (EDTA-Free, 200X): Mechanism & E
2026-07-17
The Protease Inhibitor Cocktail (EDTA-Free, 200X in DMSO) is a broad-spectrum serine protease inhibitor formulated for protein extraction. It prevents protein degradation across diverse workflows while preserving divalent cation-dependent processes. This dossier details its mechanism, supported efficacy, and practical workflow integration.
-
GSK126 EZH2 Inhibitor: Unlocking PRC2 Modulation in Pluripot
2026-07-16
Explore the GSK126 EZH2 inhibitor and its transformative role in modulating PRC2 function, with a focus on advancements in pluripotent stem cell research and oncology. This article offers a uniquely integrative perspective on assay design, bridging cancer epigenetics and regenerative biology.
-
Moesin as a Biomarker of Endothelial Injury in Sepsis: Evide
2026-07-16
This study identifies moesin (MSN) as a novel biomarker linked to endothelial injury and disease severity in sepsis, demonstrating its correlation with inflammation and vascular permeability. Experimental and patient data together highlight MSN’s mechanistic role and potential diagnostic utility in sepsis management.
-
(-)-JQ1 in BET Bromodomain Research: Precision Control and A
2026-07-15
Explore how (-)-JQ1, the JQ1 stereoisomer, enables rigorous experimental controls in epigenetics and cancer biology research. This article provides deeper insight into the design and interpretation of BET bromodomain assays, surpassing standard overviews.
-
GSK-923295: Advancing CENP-E Inhibition for Mitotic Research
2026-07-15
This thought-leadership article explores the frontier of mitotic control and centromere fidelity through the lens of GSK-923295, a potent CENP-E inhibitor. Integrating mechanistic insights and actionable guidance, we contextualize its role in translational cancer research, draw on recent discoveries around centromere maintenance factors, and provide protocol recommendations for maximizing experimental impact. This piece bridges foundational biology with strategic application, distinguishing itself from standard product summaries by directly linking evolving chromatin science to translational innovation.
-
Lisinopril Dihydrate: ACE Inhibitor Workflows for Disease Mo
2026-07-14
Lisinopril dihydrate's robust selectivity and solubility profile make it indispensable for translational hypertension, heart failure, and diabetic nephropathy research. This guide details protocol optimization, real-world troubleshooting, and cross-model insights, empowering researchers to maximize reproducibility and mechanistic clarity in cardiovascular and renal studies.
-
Cy5 amine (non-sulfonated): Technical Guide for Biomolecule
2026-07-14
Cy5 amine (non-sulfonated) addresses the need for a bright, photostable amine-functionalized dye in workflows requiring organic solvent-based labeling, such as protein or polymer conjugation for fluorescence microscopy and flow cytometry. It should not be used for direct aqueous labeling or diagnostic purposes. Careful attention to solvent compatibility, storage, and conjugation chemistry is necessary to achieve optimal results.
-
DiscoveryProbe Protease Inhibitor Library: Design Rigor and
2026-07-13
Explore how the DiscoveryProbe Protease Inhibitor Library elevates protease inhibition research through evidence-based design, rigorous validation, and practical assay insights. This article delivers a unique, in-depth analysis for advanced screening applications.
-
Tiamulin Inhibits TNF-α and Ameliorates Psoriasis-like Derma
2026-07-13
A recent study identified Tiamulin fumarate as a small-molecule inhibitor of TNF-α, demonstrating its efficacy in blocking NF-κB and MAPK signaling in vitro and alleviating psoriasis-like skin inflammation in vivo. These findings highlight Tiamulin’s potential to address unmet needs in anti-inflammatory therapy, expanding its established profile as a veterinary antibiotic.
-
MTT in Drug Resistance Reversal: Advanced Assay Insights
2026-07-12
Explore how MTT (3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide) enables deeper understanding of cell viability and metabolic activity in drug resistance research. This article uniquely bridges mechanistic assay principles with cutting-edge oncology applications.